Boehringer Ingelheim Expands Stop Rabies Initiative in Zimbabwe with AWARE
Event summary
- Boehringer Ingelheim and AWARE launch a multi-year rabies-control initiative in Zimbabwe's Tsholotsho District, targeting 15,000 dog vaccinations annually.
- The project includes free sterilization of 1,200 dogs yearly and education programs reaching 50,000 students across 85 schools.
- AWARE's veterinary hub in Tsholotsho will coordinate mobile veterinary teams to achieve over 90% vaccination coverage of the local dog population.
- The collaboration builds on AWARE's existing rabies prevention work in Zimbabwe, combining prevention, education, and community action.
The big picture
Boehringer Ingelheim's expansion of its Stop Rabies program in Zimbabwe underscores the growing emphasis on zoonotic disease prevention through collaborative, One-Health approaches. The initiative aligns with global efforts to eliminate dog-mediated human rabies deaths by 2030, as outlined by the World Health Organization. By combining veterinary interventions with community education, the partnership aims to create a sustainable model for rabies control in underserved regions.
What we're watching
- Execution Risk
- Whether Boehringer Ingelheim and AWARE can sustain high vaccination coverage in remote, resource-limited areas.
- Community Impact
- The long-term effects of education programs on rabies prevention behaviors in rural Zimbabwean communities.
- Scalability
- The pace at which this model could be replicated in other high-risk regions globally.
Related topics